Cognitive Enhancer Noopept Activates Transcription Factor HIF-1

Area of Science:

• Molecular Biology
• Neuroscience
• Biochemistry

Background:

• Hypoxia-inducible factor 1 (HIF-1) is a crucial transcription factor regulating cellular response to oxygen levels.
• HIF-1 stabilization is critical for cellular adaptation to hypoxic conditions.
• Understanding modulators of HIF-1 activity is important for therapeutic development.

Purpose of the Study:

• To investigate the effect of Noopept on HIF-1 DNA-binding activity in vitro.
• To elucidate the mechanisms by which Noopept stabilizes the HIF-1 transcription factor.
• To examine the downstream effects of Noopept on HIF-1-regulated gene expression.

Main Methods:

• In vitro studies using SH-SH5Y cells.
• Assay of basal and induced HIF-1 DNA-binding activity.
• Utilizing the ODD-Luc reporter assay to assess prolyl hydroxylase inhibition.
• Analysis of HIF1α protein levels and gene expression changes.

Main Results:

• Noopept significantly increased both basal and hypoxia-mimetic-induced HIF-1 DNA-binding activity.
• Noopept was shown to inhibit HIF-1 prolyl hydroxylase, indirectly confirmed by ODD-Luc reporter data.
• Noopept treatment led to an increased level of the HIF1α protein.
• Gene expression analysis revealed changes in pathways controlled by HIF-1.

Conclusions:

• Noopept enhances HIF-1 DNA-binding activity and stabilizes the HIF1α subunit.
• The mechanism involves the inhibition of HIF-1 prolyl hydroxylase.
• Noopept modulates gene expression related to various metabolic pathways regulated by HIF-1.